Publications by authors named "May Mabro"

Claim this Profile
C
Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma.
David Tougeron, Christophe Louvet, Jérôme Desramé, Ludovic Evesque, Antoine Angelergues, May Mabro

Commun Med (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors.
Violaine Randrian, Fabienne Portales, Olivier Bouché, Simon Thezenas, Benoist Chibaudel, May Mabro

J Neurooncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
David Tougeron, Laetitia Dahan, Ludovic Evesque, Karine Le Malicot, Farid El Hajbi, May Mabro

JAMA Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
Cindy Neuzillet, Olivier Bouché, Christophe Tournigand, Benoist Chibaudel, Lucile Bauguion, May Mabro

J Natl Compr Canc Netw· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Elisabeth S Bergen, Lorenzo Pilla, Edouard Auclin, Aysegül Ilhan-Mutlu, Gerald W Prager, May Mabro

Gastric Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics.
Henri-Corto Stoeklé, Sakina Sekkate, Elisabeth Angellier, Titouan Kennel, Asmahane Benmaziane, May Mabro

BMC Med Ethics· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy.
Sakina Sekkate, Henri-Corto Stoeklé, May Mabro, David Billard, Titouan Kennel

Eur J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Analysis of the PRODIGE-GERCOR IDEA-France Trial.
Julien Taieb, Valérie Taly, Julie Henriques, Camille Bourreau, Laurent Mineur, May Mabro

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of colorectal cancer patients with brain metastases.
Pauline Roussille, Marie Auvray, Damien Vansteene, Thierry Lecomte, Eugénie Rigault, May Mabro

Radiother Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, Karine Le Malicot, Juliette Thariat, May Mabro

Eur J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
Thierry André, Dewi Vernerey, Laurent Mineur, Jaafar Bennouna, Jérôme Desrame, May Mabro

J Clin Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.
Juliette Palle, David Tougeron, Astrid Pozet, Emilie Soularue, Pascal Artru, May Mabro

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial.
Christophe Tournigand, Benoist Chibaudel, Benoit Samson, Werner Scheithauer, Dewi Vernerey, May Mabro

Lancet Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study.
Mohamed Hebbar, Benoist Chibaudel, Thierry André, Christophe Louvet, Denis Smith, May Mabro

J Chemother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
Marie-Christine Etienne-Grimaldi, Gérard Milano, Frédérique Maindrault-Goebel, Benoist Chibaudel, Jean-Louis Formento, May Mabro

Br J Clin Pharmacol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.
Benoist Chibaudel, Frédérique Maindrault-Goebel, Gérard Lledo, Laurent Mineur, Thierry André, May Mabro

J Clin Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical treatment of rectal cancer: results of a strategy for selective preoperative radiotherapy.
Pascal Frileux, Gaëlle Burdy, Philippe Aegerter, Geneviève Dubost, Michèle Bernier, May Mabro

Gastroenterol Clin Biol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Primary retroperitoneal synovial sarcoma revealed by hemorrhagic shock].
Nicolas Girszyn, May Mabro, Jean-Emmanuel Kahn, Jean-Claude Roullet-Audy, Anne Sautet

Presse Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).
Mohamed Hebbar, Christophe Tournigand, Gérard Lledo, May Mabro, Thierry André

Cancer Invest· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimonthly leucovorin, infusion 5-fluorouracil, hydroxyurea, and irinotecan (FOLFIRI-2) for pretreated metastatic colorectal cancer.
May Mabro, Christophe Louvet, Thierry André, Elisabeth Carola, Véronique Gilles-Amar

Am J Clin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factor analysis in advanced gastric cancer patients treated with hydroxyurea, leucovorin, 5-fluorouracil, and cisplatin (HLFP regimen).
Christophe Louvet, Fabien Carrat, Frédéric Mal, May Mabro, Karine Beerblock

Cancer Invest· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Annual Congress of the American Society of Clinical Oncology, Orlando, Florida, May 2002: update on breast and digestive cancer].
May Mabro

Rev Med Interne· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis